Shelton Ann K, Fish Anne F, Cobb J Perren, Bachman Jean A, Jenkins Ruth L, Battistich Victor, Freeman Bradley D
ITT-Technical Institute, St Louis, Missouri, USA.
Am J Crit Care. 2009 Sep;18(5):418-26; quiz 427. doi: 10.4037/ajcc2009473.
Surrogate decision makers may be poorly prepared to give informed consent for genomics research for their loved ones in intensive care. A review of the challenges and strategies associated with obtaining surrogates' consent for genomics research in intensive care patients revealed that few well-controlled studies have been done on this topic. Yet, a major theme in the literature is the role of health care professionals in guiding surrogates through the informed consent process rather than simply witnessing a signature. Informed consent requires explicit strategies to approach potential surrogates effectively, educate them, and ensure that informed consent has been attained.
在重症监护室中，替代决策者可能没有充分准备好为其亲人的基因组学研究提供知情同意。一项关于在重症监护患者中获得替代者对基因组学研究同意的挑战和策略的综述显示，关于这个主题的严格对照研究很少。然而，文献中的一个主要主题是医疗保健专业人员在指导替代者完成知情同意过程中的作用，而不仅仅是见证签名。知情同意需要明确的策略来有效地接触潜在的替代者，对他们进行教育，并确保获得了知情同意。
